Skip to content

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Incidence, Risk factors, and Outcomes of Thromboembolism in Patients with Melanoma Receiving Immune Checkpoint Inhibitors, Chemotherapy, or Targeted Therapy: a SEER-Medicare Analysis.

BACKGROUND Little is known about venous thromboembolism (VTE) and arterial thromboembolism (ATE) risk in melanoma patients receiving immune checkpoint inhibitors (ICI), compared to other therapies. OBJECTIVES We assessed incidence, risk factors, and impact on survival of thromboembolism (TE) in patients receiving ICI...

T. Sussman, Long Vu, S. Koroukian et al. · 0 citations
Sep 2026

Missed Precision: Gaps in Molecular Profiling Among Medicaid Patients With Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer.

PURPOSE Molecular profiling (MP) informs precision oncology in estrogen receptor-positive, human epidermal growth factor receptor 2-negative (ER+/HER2-) breast cancer, yet uptake within Medicaid is poorly characterized. We assessed MP receipt and associated factors among Ohio Medicaid beneficiaries with nonmetastatic E...

Trisha Lal, Long Vu, Reine Abou Zeidane et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.